Start with its own history
At 86.74×, NTUS is 37.4% above its 6-observation annual average. A lower multiple can reflect a lower price, higher earnings, or weaker growth expectations—not necessarily a bargain.

Current valuation, historical context, and peer comparisons.
Current P/E ratio
86.74×
37.4% abovethe 6-observation annual average
Price and EPS in quote currency. Calculation details
Investors are paying 86.74 for every 1 of reported earnings per share.
Annual period-end data · 21 observations
| Period end | P/E | Change |
|---|---|---|
| Dec 31, 2021 | 60.85× | N/M |
| Dec 31, 2020 | N/M | N/M |
| Dec 31, 2019 | N/M | N/M |
| Dec 31, 2018 | N/M | N/M |
| Dec 31, 2017 | N/M | N/M |
| Dec 31, 2016 | 20.92× | -10.7% |
| Dec 31, 2015 | 23.43× | -12.0% |
| Dec 31, 2014 | 26.61× | -26.2% |
| Period end | P/E | Change |
|---|---|---|
| Dec 31, 2013 | 36.07× | -82.9% |
| Dec 31, 2012 | 210.85× | N/M |
| Dec 31, 2011 | N/M | N/M |
| Dec 31, 2010 | 65.26× | -4.8% |
| Dec 31, 2009 | 68.52× | +72.5% |
| Dec 31, 2008 | 39.72× | -34.8% |
| Dec 31, 2007 | 60.91× | N/M |
| Dec 31, 2006 | N/M | N/M |
| Dec 31, 2005 | 78.31× | N/M |
| Dec 31, 2004 | N/M | N/M |
| Dec 31, 2003 | N/M | N/M |
| Dec 31, 2002 | N/M | N/M |
| Dec 31, 2001 | N/M | N/M |
Change is relative to the preceding observation. N/M values are excluded from averages.
Company P/E vs. peer trailing-12-month ratios
| Company | P/E ratio |
|---|---|
NTUS This stockNatus Medical Incorporated | 86.74× |
SILKSilk Road Medical, Inc | N/M |
FNAParagon 28, Inc. | N/M |
HSKAHeska Corporation | N/M |
EQRXEQRx, Inc. | 5.44× |
CSIICardiovascular Systems, Inc. | N/M |
ETHZEthzilla Corp. | N/M |
CTICCTI BioPharma Corp. | N/M |
VECTVectivBio Holding AG | N/M |
Peers are selected by the data provider. Business models and earnings definitions can differ.
Put the numbers in context
At 86.74×, NTUS is 37.4% above its 6-observation annual average. A lower multiple can reflect a lower price, higher earnings, or weaker growth expectations—not necessarily a bargain.
The median of the 1 positive peer ratios above is 5.44×. Check growth, margins, debt, and earnings quality before interpreting the gap. A faster-growing business may justify a higher multiple.
One-off gains can temporarily lower P/E; unusual charges can raise it. Reported earnings and forward estimates answer different questions. Pair this view with return on equity and liquidity for a fuller picture.
Keep your research connected
Pull historical P/E into Excel or Google Sheets with Wisesheets. Build your own comparisons alongside the rest of your financial model.
Explore Wisesheets=WISE("NTUS", "PE Ratio", "LQ")Share price 32.96 ÷ EPS 0.38 = 86.74×. Data is supplied by Financial Modeling Prep through Wisesheets. Quote feed updated Not supplied; this is not a real-time trading quote.
Annual and quarterly P/E observations are provided separately from the current quote. Averages use the latest 3, 5, or 10 annual observations, excluding missing and nonpositive ratios. Pre-IPO observations are omitted. These are period-end observations, not daily averages.
The current quote feed does not specify the exact EPS filing-period end or whether EPS is basic or diluted. We do not label it as forward P/E. Peer ratios are explicitly trailing-12-month (TTM) values. Historical observations do not include independently verified price and EPS inputs. Sources may update on different schedules; rounded inputs can produce small calculation differences. Historical comparisons describe past pricing, not an estimate of fair value.
The essentials behind the numbers.